Literature DB >> 12929739

Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line.

Maria Teresa Conconi1, Silvia Baiguera, Diego Guidolin, Claudio Furlan, Anna M Menti, Simonetta Vigolo, Anna S Belloni, Pier Paolo Parnigotto, Gastone G Nussdorfer.   

Abstract

BACKGROUND: Hyperbaric oxygen (HBO) therapy is widely used to treat problem wounds associated with pathologic conditions compromising blood supply and tissue oxygenation because increased tissue oxygen levels enhance collagen synthesis, cell proliferation, and angiogenesis. However, little is known about the dose of hyperoxia needed to achieve optimal therapeutic effects. Moreover, HBO, by enhancing the production of reactive oxygen species (ROS), may also exert cytotoxic effects. In vitro models are simplified systems that may aid the development of treatment protocols with HBO. Hence, we have investigated the effects of HBO on the growth and ROS production of the 3T3/J2 fibroblast cell line in relation to the pressure and the duration of exposure.
METHODS: 3T3/J2 fibroblasts were plated (5 x 10(3) cells/cm2) on six-well microtiter plates in phosphate buffered saline (PBS), put in a compression chamber, and exposed to 100% oxygen at a pressure of 1.0 or 2.5 atmosphere absolute (ATA) for 15, 30, 60, or 120 minutes. Then the cells were incubated in Dulbecco's modified minimum essential medium (DMEM) for 24, 48, or 72 hours, and at the end of the post-HBO incubation period, their number was determined. In other experiments, cells were detached just after HBO exposure, seeded on 60 mm Petri dishes, and cultured for 10 days in DMEM, and the colony forming units were counted. The effects of HBO exposure (2.5 ATA) on the apoptotic rate of cultured cells were investigated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) and enzyme-linked immunosorbent assays. To measure ROS production, 60 minutes before HBO exposure, 2',7'-dichlorofluorescin (DCF) diacetate (200 nmol/mL) was added to PBS, and after HBO exposure (2.5 ATA), cells were lysated, and fluorescence-emission intensity was measured and converted to micromol DCF/microg protein.
RESULTS: At 1.0 ATA, all HBO exposures increased the proliferation rate of cultured fibroblasts and their clonal growth efficiency. At 2.5 ATA, 15-minute exposure to HBO was ineffective, whereas 30- and 60-minute exposures raised the proliferation rate and clonal growth efficiency. Conversely, a 120-minute exposure significantly decreased these parameters compared with control cultures. The exposure of cells to HBO at 2.5 ATA for 120 minutes raised the apoptotic rate of cultured fibroblasts, whereas shorter exposure times were ineffective. All exposure periods to HBO at 2.5 ATA enhanced ROS production from cultured fibroblasts.
CONCLUSIONS: Collectively, our findings allow us to conclude that (1) all of the exposure periods to HBO at 1.0 ATA or 30- and 60-minute periods at 2.5 ATA enhance cell growth, (2) 120-minute exposure to HBO at 2.5 ATA exerts a marked proapoptotic effect, and (3) no evident relationships occur between the effects of HBO on cell growth and ROS production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929739     DOI: 10.1136/jim-51-04-24

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  18 in total

Review 1.  Topical oxygen therapy & micro/nanobubbles: a new modality for tissue oxygen delivery.

Authors:  Lohrasb R Sayadi; Derek A Banyard; Mary E Ziegler; Zaidal Obagi; Jordyne Prussak; Michael J Klopfer; Gregory Rd Evans; Alan D Widgerow
Journal:  Int Wound J       Date:  2018-01-05       Impact factor: 3.315

2.  Effects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes.

Authors:  P Quintero; P González-Muniesa; D F García-Díaz; J A Martínez
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

Review 3.  Hyperbaric Oxygen Therapy-A Novel Treatment Modality in Oral Submucous Fibrosis: A Review.

Authors:  M Ashwini Kumar; Besta Radhika; Nishanth Gollamudi; Satya Prakash Reddy; Uday Shankar Yaga
Journal:  J Clin Diagn Res       Date:  2015-05-01

4.  Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis.

Authors:  Yong-Gang Wang; Yi-Ping Zhan; Shu-Yi Pan; Hai-Dong Wang; Dun-Xiao Zhang; Kai Gao; Xue-Ling Qi; Chun-Jiang Yu
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

5.  Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats.

Authors:  Qin Hu; Xiping Liang; Di Chen; Yujie Chen; Desislava Doycheva; Junjia Tang; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

6.  The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following in vitro stress in human monocytes.

Authors:  Rebecca V Vince; Adrian W Midgley; Gerard Laden; Leigh A Madden
Journal:  Cell Stress Chaperones       Date:  2010-12-05       Impact factor: 3.667

Review 7.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

8.  Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis.

Authors:  Dmitry Kondrikov; Ruth B Caldwell; Zheng Dong; Yunchao Su
Journal:  Free Radic Biol Med       Date:  2011-03-23       Impact factor: 7.376

9.  Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.

Authors:  Linda Elin Birkhaug Stuhr; A Raa; A M Oyan; K H Kalland; P O Sakariassen; K Petersen; R Bjerkvig; R K Reed
Journal:  J Neurooncol       Date:  2007-06-08       Impact factor: 4.130

10.  The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis.

Authors:  Jixiang Ni; Zheng Dong; Weihong Han; Dmitry Kondrikov; Yunchao Su
Journal:  Free Radic Biol Med       Date:  2013-03-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.